However, when considering weight, the reduction in mortality was only significant for people with substantial obesity, indicated by a BMI above 35
Di Miceli JFF, Andrade MER, Carvalho PLA, Santos EA, Faria Mota Oliveira AEMD, Fernandes CP, et al
Writable vial labels
During a mean (SD) follow-up of 2.5 (1.7) years, 77 suicide deaths occurred among users of GLP-1 receptor agonists and 71 suicide deaths occurred among users of SGLT2 inhibitors: weighted incidences were 0.23 vs 0.18 events per 1000 person-years (HR, 1.25
While, under this authority, we would ordinarily use the ASP methodology under section 1847A of the Act, we continued to find that the ASP data we had was not usable for payment purposes
666918 and the NIHR GOSH BRC (the views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health)